COMP · Compass, Inc. · Stock research

Current Thesis

Compass closed its ~$1.6B all-stock acquisition of Anywhere Real Estate on 2026-01-09, becoming the largest US residential brokerage roughly 200k+ agents (340k+ including franchisees) and the Coldwell Banker, Century 21 and Sotheby's International Realty brands folded in. The narrative leg an investor is buying is a synergy-driven EBITDA inflection: Q1 2026 (reported 2026-05-05) printed revenue of $2.704B (+99% YoY), the first GAAP net income ($22M) and adjusted EBITDA of $61M, and management lifted the FY26 actioned-synergy target from $250M to $300M and realized synergies from $100M to $200M after actioning >$250M within 82 days of close. The Q2 guide is a step-change $4.0–4.2B revenue, $310–350M adjusted EBITDA. The complication that arrived in June: NY AG Letitia James opened an antitrust probe (~2026-06-03) into the combined New York footprint, and the clean re-rate now carries an open-ended regulatory cloud.

Bullish and bearish views on Compass, Inc.

The model's bull view on Compass, Inc. (COMP), in brief: Q1 2026 revenue $2.704B, +99% YoY versus $1.36B in Q1 2025; first GAAP profit of $22M; adjusted EBITDA $61M reported 2026-05-05, the first full quarter as a combined company. The bear view: NY AG antitrust probe opened ~2026-06-03 is open-ended and could demand New York divestitures or cap expansion; a November Capstone analysis projected >30% combined New York market share. Both cases follow in full.

Bull Case

• Q1 2026 revenue $2.704B, +99% YoY versus $1.36B in Q1 2025; first GAAP profit of $22M; adjusted EBITDA $61M reported 2026-05-05, the first full quarter as a combined company.
• Synergy guidance raised twice in one print: actioned target $250M→$300M, realized $100M→$200M, with >$250M actioned inside 82 days of the 2026-01-09 close integration is running ahead of plan.
• Q2 2026 guide of $4.0–4.2B revenue / $310–350M adjusted EBITDA is a seasonal-plus-full-Anywhere-quarter step-change; if hit, it annualizes to a margin profile the ~$8.5B market cap is not yet discounting.
• Scale leadership: agent count went from ~40k pre-deal to 200k+; pro forma Brokerage GTV +7.3% YoY and Franchise GTV +4.6% YoY in Q1 transaction volume inflecting positive.
• Morgan Stanley (Matthew Cost) raised its target to $12.50 from $11 (Equal Weight); Street median sits near $13.00 across 17 analysts with a $17 high, leaving room above the ~$11.40 spot.

Bear Case

• NY AG antitrust probe opened ~2026-06-03 is open-ended and could demand New York divestitures or cap expansion; a November Capstone analysis projected >30% combined New York market share. The headline gapped the stock down ~12–13% in a session.
• Federal clearance is politically contested: DOJ Deputy AG Todd Blanche overruled staff to bypass an extended review in January, and 19 Democratic senators alleged "corruption" keeping regulatory tail-risk in the news flow.
• Goldman Sachs (Michael Ng) cut its target to $10.50 from $12 with a Neutral rating, putting a credible analyst floor below the current price.
• The core is cyclical: brokerage GTV is hostage to mortgage rates (still ~6.5–7%) and existing-home-sales turnover; a rate back-up or a stalled spring/summer season caps the volume tailwind.
• Beta of 2.44 and a $6.09–$13.96 52-week band make this a high-amplitude integration-risk name, and the merger already expanded the share count materially.

Setup & Price Structure

• Spot ~$11.40 on 2026-06-26 and ~$11.17 on 2026-06-27; intraday range $10.93–$11.57.
• 52-week range $6.09–$13.96; up ~78% YoY; price sits mid-band, roughly 18% under the $13.96 high.
• The early-June AG headline produced a ~12–13% gap-down; price has since stabilized into a $10.9–11.5 shelf rather than breaking lower.
• The analyst target cluster around $13.00–13.17 sits ~15–19% above spot, while Goldman's $10.50 marks the bearish line near post-dip support.
• This is a mid-range consolidation, not a clean breakout a fresh regulatory gap overhangs the approach to the highs, with defined risk just under $10.

Catalyst Calendar (next 30 days)

• ~2026-07-29 (est.) Q2 2026 earnings. Binary on the $4.0–4.2B revenue / $310–350M adjusted EBITDA guide and updated synergy realization; sits just past the 30-day window edge. Pre-print blackout risk applies.
• Ongoing NY AG antitrust inquiry. Any subpoena/CID, divestiture demand or narrowing/settlement headline is a discrete, unscheduled catalyst in either direction.
• Macro July housing prints (existing-home sales, mortgage-rate path) feed the GTV tape that drives commission revenue.

What Would Change Our Mind

• A weekly close below $10 loses the post-AG-dip recovery shelf and Goldman's $10.50 floor, signaling the antitrust-plus-cyclical overhang is overwhelming the synergy re-rate; under that, the $6–8 pre-merger zone is back in play.
• A formal NY AG action demanding New York-market divestitures would structurally impair both the synergy math and the scale thesis.
• A Q2 miss versus the $4.0–4.2B / $310–350M guide breaks the EBITDA-inflection story the multiple leans on.
• On the other side, a reclaim of the $13.96 high with the AG probe resolved or narrowed flips this from overhang-capped to a clean breakout.

Correlation Notes

• Moves with the housing-turnover cohort brokerage and rate-sensitive real-estate names and is geared to existing-home-sales volume and the 30-year mortgage path more than to home prices.
• Inverse to the 10-year yield / mortgage-rate impulse: a rate back-up pressures GTV; a rate-cut path is the tailwind that feeds commission volume.
• Carries an idiosyncratic regulatory beta the NY AG probe is COMP-specific and decouples the stock from the housing cohort on headline days.
• A 2.44 beta means it amplifies the housing theme's direction in both tails relative to homebuilders and iBuyer peers.